nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—UGT2B7—Pitavastatin—coronary artery disease	0.103	0.192	CbGbCtD
Epirubicin—UGT2B7—Ezetimibe—coronary artery disease	0.076	0.141	CbGbCtD
Epirubicin—UGT2B7—Simvastatin—coronary artery disease	0.0706	0.131	CbGbCtD
Epirubicin—UGT2B7—Lovastatin—coronary artery disease	0.0691	0.129	CbGbCtD
Epirubicin—UGT2B7—Atorvastatin—coronary artery disease	0.063	0.117	CbGbCtD
Epirubicin—UGT2B7—Losartan—coronary artery disease	0.0576	0.107	CbGbCtD
Epirubicin—ABCC1—Rosuvastatin—coronary artery disease	0.054	0.1	CbGbCtD
Epirubicin—ABCC1—Atorvastatin—coronary artery disease	0.0447	0.0831	CbGbCtD
Epirubicin—CHD1—cardiac ventricle—coronary artery disease	0.00374	0.0921	CbGeAlD
Epirubicin—CHD1—myocardium—coronary artery disease	0.00352	0.0867	CbGeAlD
Epirubicin—AURKA—myocardium—coronary artery disease	0.00284	0.0699	CbGeAlD
Epirubicin—CHD1—heart—coronary artery disease	0.00246	0.0605	CbGeAlD
Epirubicin—YWHAG—cardiac ventricle—coronary artery disease	0.00232	0.057	CbGeAlD
Epirubicin—YWHAG—myocardium—coronary artery disease	0.00218	0.0536	CbGeAlD
Epirubicin—CHD1—cardiac atrium—coronary artery disease	0.0021	0.0517	CbGeAlD
Epirubicin—AURKA—heart—coronary artery disease	0.00198	0.0488	CbGeAlD
Epirubicin—CHD1—blood—coronary artery disease	0.00183	0.0451	CbGeAlD
Epirubicin—Doxorubicin—RALBP1—coronary artery disease	0.00175	0.552	CrCbGaD
Epirubicin—DHCR7—heart—coronary artery disease	0.00166	0.0408	CbGeAlD
Epirubicin—YWHAG—heart—coronary artery disease	0.00152	0.0374	CbGeAlD
Epirubicin—AURKA—blood—coronary artery disease	0.00148	0.0364	CbGeAlD
Epirubicin—YWHAG—cardiovascular system—coronary artery disease	0.00143	0.0353	CbGeAlD
Epirubicin—DHCR7—cardiac atrium—coronary artery disease	0.00142	0.0349	CbGeAlD
Epirubicin—YWHAG—cardiac atrium—coronary artery disease	0.0013	0.032	CbGeAlD
Epirubicin—DHCR7—blood—coronary artery disease	0.00124	0.0304	CbGeAlD
Epirubicin—YWHAG—blood—coronary artery disease	0.00113	0.0279	CbGeAlD
Epirubicin—PLA2G4A—heart—coronary artery disease	0.00113	0.0279	CbGeAlD
Epirubicin—PLA2G4A—cardiovascular system—coronary artery disease	0.00107	0.0263	CbGeAlD
Epirubicin—ABCC1—myocardium—coronary artery disease	0.000929	0.0229	CbGeAlD
Epirubicin—CHD1—Pitavastatin—Rosuvastatin—coronary artery disease	0.000882	0.166	CbGdCrCtD
Epirubicin—PLA2G4A—blood—coronary artery disease	0.000846	0.0208	CbGeAlD
Epirubicin—TOP2A—blood—coronary artery disease	0.000804	0.0198	CbGeAlD
Epirubicin—CHD1—Pitavastatin—Atorvastatin—coronary artery disease	0.00075	0.141	CbGdCrCtD
Epirubicin—Doxorubicin—NOS3—coronary artery disease	0.000723	0.228	CrCbGaD
Epirubicin—Doxorubicin—NOS2—coronary artery disease	0.000698	0.22	CrCbGaD
Epirubicin—ABCC1—heart—coronary artery disease	0.000649	0.016	CbGeAlD
Epirubicin—ABCC1—cardiac atrium—coronary artery disease	0.000555	0.0137	CbGeAlD
Epirubicin—ABCC1—blood—coronary artery disease	0.000484	0.0119	CbGeAlD
Epirubicin—PLA2G4A—Enalapril—Captopril—coronary artery disease	0.000437	0.0825	CbGdCrCtD
Epirubicin—AURKA—Fluvastatin—Pitavastatin—coronary artery disease	0.000399	0.0753	CbGdCrCtD
Epirubicin—AURKA—Fluvastatin—Rosuvastatin—coronary artery disease	0.000356	0.0671	CbGdCrCtD
Epirubicin—AURKA—Simvastatin—Lovastatin—coronary artery disease	0.00034	0.0641	CbGdCrCtD
Epirubicin—AURKA—Simvastatin—Pravastatin—coronary artery disease	0.00034	0.0641	CbGdCrCtD
Epirubicin—AURKA—Fluvastatin—Atorvastatin—coronary artery disease	0.000302	0.057	CbGdCrCtD
Epirubicin—PLA2G4A—Enalapril—Perindopril—coronary artery disease	0.000236	0.0445	CbGdCrCtD
Epirubicin—PLA2G4A—Enalapril—Trandolapril—coronary artery disease	0.000184	0.0348	CbGdCrCtD
Epirubicin—TOP2A—Fluvastatin—Pitavastatin—coronary artery disease	0.000152	0.0288	CbGdCrCtD
Epirubicin—PLA2G4A—Enalapril—Lisinopril—coronary artery disease	0.000144	0.0272	CbGdCrCtD
Epirubicin—PLA2G4A—Enalapril—Ramipril—coronary artery disease	0.00014	0.0263	CbGdCrCtD
Epirubicin—TOP2A—Fluvastatin—Rosuvastatin—coronary artery disease	0.000136	0.0256	CbGdCrCtD
Epirubicin—TOP2A—Simvastatin—Pravastatin—coronary artery disease	0.00013	0.0245	CbGdCrCtD
Epirubicin—TOP2A—Simvastatin—Lovastatin—coronary artery disease	0.00013	0.0245	CbGdCrCtD
Epirubicin—TOP2A—Fluvastatin—Atorvastatin—coronary artery disease	0.000116	0.0218	CbGdCrCtD
Epirubicin—TOP2A—Alprenolol—Penbutolol—coronary artery disease	7.44e-05	0.014	CbGdCrCtD
Epirubicin—TOP2A—Methyltestosterone—Eplerenone—coronary artery disease	5.17e-05	0.00976	CbGdCrCtD
Epirubicin—Malaise—Lisinopril—coronary artery disease	3.94e-05	0.000148	CcSEcCtD
Epirubicin—Oedema—Ramipril—coronary artery disease	3.93e-05	0.000148	CcSEcCtD
Epirubicin—Anaphylactic shock—Ramipril—coronary artery disease	3.93e-05	0.000148	CcSEcCtD
Epirubicin—Vertigo—Lisinopril—coronary artery disease	3.93e-05	0.000148	CcSEcCtD
Epirubicin—Dry mouth—Timolol—coronary artery disease	3.92e-05	0.000148	CcSEcCtD
Epirubicin—Pain—Losartan—coronary artery disease	3.92e-05	0.000148	CcSEcCtD
Epirubicin—Constipation—Losartan—coronary artery disease	3.92e-05	0.000148	CcSEcCtD
Epirubicin—Syncope—Lisinopril—coronary artery disease	3.92e-05	0.000147	CcSEcCtD
Epirubicin—Vomiting—Eplerenone—coronary artery disease	3.92e-05	0.000147	CcSEcCtD
Epirubicin—Feeling abnormal—Furosemide—coronary artery disease	3.92e-05	0.000147	CcSEcCtD
Epirubicin—Leukopenia—Lisinopril—coronary artery disease	3.91e-05	0.000147	CcSEcCtD
Epirubicin—Nausea—Fenofibrate—coronary artery disease	3.91e-05	0.000147	CcSEcCtD
Epirubicin—Pruritus—Niacin—coronary artery disease	3.9e-05	0.000147	CcSEcCtD
Epirubicin—Asthenia—Pravastatin—coronary artery disease	3.9e-05	0.000147	CcSEcCtD
Epirubicin—Gastrointestinal pain—Furosemide—coronary artery disease	3.89e-05	0.000146	CcSEcCtD
Epirubicin—Rash—Eplerenone—coronary artery disease	3.89e-05	0.000146	CcSEcCtD
Epirubicin—Urticaria—Perindopril—coronary artery disease	3.89e-05	0.000146	CcSEcCtD
Epirubicin—Hypersensitivity—Trandolapril—coronary artery disease	3.89e-05	0.000146	CcSEcCtD
Epirubicin—Dermatitis—Eplerenone—coronary artery disease	3.88e-05	0.000146	CcSEcCtD
Epirubicin—Diarrhoea—Valsartan—coronary artery disease	3.88e-05	0.000146	CcSEcCtD
Epirubicin—Confusional state—Timolol—coronary artery disease	3.88e-05	0.000146	CcSEcCtD
Epirubicin—Shock—Ramipril—coronary artery disease	3.87e-05	0.000146	CcSEcCtD
Epirubicin—Hypersensitivity—Enalapril—coronary artery disease	3.87e-05	0.000146	CcSEcCtD
Epirubicin—Abdominal pain—Perindopril—coronary artery disease	3.87e-05	0.000145	CcSEcCtD
Epirubicin—Body temperature increased—Perindopril—coronary artery disease	3.87e-05	0.000145	CcSEcCtD
Epirubicin—Palpitations—Lisinopril—coronary artery disease	3.86e-05	0.000145	CcSEcCtD
Epirubicin—Diarrhoea—Olmesartan—coronary artery disease	3.86e-05	0.000145	CcSEcCtD
Epirubicin—Headache—Eplerenone—coronary artery disease	3.86e-05	0.000145	CcSEcCtD
Epirubicin—Nervous system disorder—Ramipril—coronary artery disease	3.86e-05	0.000145	CcSEcCtD
Epirubicin—Thrombocytopenia—Ramipril—coronary artery disease	3.85e-05	0.000145	CcSEcCtD
Epirubicin—Oedema—Timolol—coronary artery disease	3.85e-05	0.000145	CcSEcCtD
Epirubicin—Anaphylactic shock—Timolol—coronary artery disease	3.85e-05	0.000145	CcSEcCtD
Epirubicin—Pruritus—Pravastatin—coronary artery disease	3.84e-05	0.000145	CcSEcCtD
Epirubicin—Loss of consciousness—Lisinopril—coronary artery disease	3.84e-05	0.000145	CcSEcCtD
Epirubicin—Nausea—Clopidogrel—coronary artery disease	3.84e-05	0.000144	CcSEcCtD
Epirubicin—Tachycardia—Ramipril—coronary artery disease	3.84e-05	0.000144	CcSEcCtD
Epirubicin—Skin disorder—Ramipril—coronary artery disease	3.82e-05	0.000144	CcSEcCtD
Epirubicin—Infection—Timolol—coronary artery disease	3.82e-05	0.000144	CcSEcCtD
Epirubicin—Vomiting—Simvastatin—coronary artery disease	3.82e-05	0.000144	CcSEcCtD
Epirubicin—Hypersensitivity—Telmisartan—coronary artery disease	3.82e-05	0.000144	CcSEcCtD
Epirubicin—Cough—Lisinopril—coronary artery disease	3.82e-05	0.000143	CcSEcCtD
Epirubicin—Nausea—Lovastatin—coronary artery disease	3.82e-05	0.000143	CcSEcCtD
Epirubicin—Hyperhidrosis—Ramipril—coronary artery disease	3.8e-05	0.000143	CcSEcCtD
Epirubicin—Rash—Simvastatin—coronary artery disease	3.79e-05	0.000142	CcSEcCtD
Epirubicin—Dermatitis—Simvastatin—coronary artery disease	3.78e-05	0.000142	CcSEcCtD
Epirubicin—Asthenia—Trandolapril—coronary artery disease	3.78e-05	0.000142	CcSEcCtD
Epirubicin—Shock—Timolol—coronary artery disease	3.78e-05	0.000142	CcSEcCtD
Epirubicin—Feeling abnormal—Losartan—coronary artery disease	3.78e-05	0.000142	CcSEcCtD
Epirubicin—Urticaria—Furosemide—coronary artery disease	3.78e-05	0.000142	CcSEcCtD
Epirubicin—Diarrhoea—Niacin—coronary artery disease	3.77e-05	0.000142	CcSEcCtD
Epirubicin—Nervous system disorder—Timolol—coronary artery disease	3.77e-05	0.000142	CcSEcCtD
Epirubicin—Asthenia—Enalapril—coronary artery disease	3.77e-05	0.000142	CcSEcCtD
Epirubicin—Headache—Simvastatin—coronary artery disease	3.76e-05	0.000142	CcSEcCtD
Epirubicin—Abdominal pain—Furosemide—coronary artery disease	3.76e-05	0.000141	CcSEcCtD
Epirubicin—Body temperature increased—Furosemide—coronary artery disease	3.76e-05	0.000141	CcSEcCtD
Epirubicin—Gastrointestinal pain—Losartan—coronary artery disease	3.75e-05	0.000141	CcSEcCtD
Epirubicin—Dizziness—Valsartan—coronary artery disease	3.75e-05	0.000141	CcSEcCtD
Epirubicin—Anorexia—Ramipril—coronary artery disease	3.75e-05	0.000141	CcSEcCtD
Epirubicin—Nausea—Ezetimibe—coronary artery disease	3.74e-05	0.000141	CcSEcCtD
Epirubicin—Skin disorder—Timolol—coronary artery disease	3.74e-05	0.000141	CcSEcCtD
Epirubicin—Dizziness—Olmesartan—coronary artery disease	3.73e-05	0.00014	CcSEcCtD
Epirubicin—Pruritus—Trandolapril—coronary artery disease	3.73e-05	0.00014	CcSEcCtD
Epirubicin—Chest pain—Lisinopril—coronary artery disease	3.72e-05	0.00014	CcSEcCtD
Epirubicin—Myalgia—Lisinopril—coronary artery disease	3.72e-05	0.00014	CcSEcCtD
Epirubicin—Arthralgia—Lisinopril—coronary artery disease	3.72e-05	0.00014	CcSEcCtD
Epirubicin—Hyperhidrosis—Timolol—coronary artery disease	3.72e-05	0.00014	CcSEcCtD
Epirubicin—Asthenia—Telmisartan—coronary artery disease	3.72e-05	0.00014	CcSEcCtD
Epirubicin—Pruritus—Enalapril—coronary artery disease	3.72e-05	0.00014	CcSEcCtD
Epirubicin—Diarrhoea—Pravastatin—coronary artery disease	3.72e-05	0.00014	CcSEcCtD
Epirubicin—Anxiety—Lisinopril—coronary artery disease	3.71e-05	0.000139	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	3.7e-05	0.000139	CcSEcCtD
Epirubicin—Discomfort—Lisinopril—coronary artery disease	3.68e-05	0.000138	CcSEcCtD
Epirubicin—Hypotension—Ramipril—coronary artery disease	3.68e-05	0.000138	CcSEcCtD
Epirubicin—Anorexia—Timolol—coronary artery disease	3.67e-05	0.000138	CcSEcCtD
Epirubicin—Pruritus—Telmisartan—coronary artery disease	3.67e-05	0.000138	CcSEcCtD
Epirubicin—Nausea—Eplerenone—coronary artery disease	3.66e-05	0.000138	CcSEcCtD
Epirubicin—Dizziness—Niacin—coronary artery disease	3.65e-05	0.000137	CcSEcCtD
Epirubicin—Urticaria—Losartan—coronary artery disease	3.65e-05	0.000137	CcSEcCtD
Epirubicin—Dry mouth—Lisinopril—coronary artery disease	3.64e-05	0.000137	CcSEcCtD
Epirubicin—Abdominal pain—Losartan—coronary artery disease	3.63e-05	0.000136	CcSEcCtD
Epirubicin—Body temperature increased—Losartan—coronary artery disease	3.63e-05	0.000136	CcSEcCtD
Epirubicin—Asthenia—Captopril—coronary artery disease	3.62e-05	0.000136	CcSEcCtD
Epirubicin—Diarrhoea—Trandolapril—coronary artery disease	3.61e-05	0.000136	CcSEcCtD
Epirubicin—Vomiting—Valsartan—coronary artery disease	3.61e-05	0.000136	CcSEcCtD
Epirubicin—Confusional state—Lisinopril—coronary artery disease	3.6e-05	0.000135	CcSEcCtD
Epirubicin—Diarrhoea—Enalapril—coronary artery disease	3.59e-05	0.000135	CcSEcCtD
Epirubicin—Hypotension—Timolol—coronary artery disease	3.59e-05	0.000135	CcSEcCtD
Epirubicin—Dizziness—Pravastatin—coronary artery disease	3.59e-05	0.000135	CcSEcCtD
Epirubicin—Vomiting—Olmesartan—coronary artery disease	3.59e-05	0.000135	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Ramipril—coronary artery disease	3.58e-05	0.000135	CcSEcCtD
Epirubicin—Rash—Valsartan—coronary artery disease	3.58e-05	0.000135	CcSEcCtD
Epirubicin—Dermatitis—Valsartan—coronary artery disease	3.57e-05	0.000134	CcSEcCtD
Epirubicin—Nausea—Simvastatin—coronary artery disease	3.57e-05	0.000134	CcSEcCtD
Epirubicin—Oedema—Lisinopril—coronary artery disease	3.57e-05	0.000134	CcSEcCtD
Epirubicin—Anaphylactic shock—Lisinopril—coronary artery disease	3.57e-05	0.000134	CcSEcCtD
Epirubicin—Pruritus—Captopril—coronary artery disease	3.56e-05	0.000134	CcSEcCtD
Epirubicin—Rash—Olmesartan—coronary artery disease	3.56e-05	0.000134	CcSEcCtD
Epirubicin—Insomnia—Ramipril—coronary artery disease	3.56e-05	0.000134	CcSEcCtD
Epirubicin—Dermatitis—Olmesartan—coronary artery disease	3.56e-05	0.000134	CcSEcCtD
Epirubicin—Headache—Valsartan—coronary artery disease	3.55e-05	0.000134	CcSEcCtD
Epirubicin—Diarrhoea—Telmisartan—coronary artery disease	3.55e-05	0.000133	CcSEcCtD
Epirubicin—Infection—Lisinopril—coronary artery disease	3.54e-05	0.000133	CcSEcCtD
Epirubicin—Headache—Olmesartan—coronary artery disease	3.54e-05	0.000133	CcSEcCtD
Epirubicin—Paraesthesia—Ramipril—coronary artery disease	3.53e-05	0.000133	CcSEcCtD
Epirubicin—Shock—Lisinopril—coronary artery disease	3.51e-05	0.000132	CcSEcCtD
Epirubicin—Asthenia—Perindopril—coronary artery disease	3.51e-05	0.000132	CcSEcCtD
Epirubicin—Dyspnoea—Ramipril—coronary artery disease	3.51e-05	0.000132	CcSEcCtD
Epirubicin—Vomiting—Niacin—coronary artery disease	3.51e-05	0.000132	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Timolol—coronary artery disease	3.5e-05	0.000132	CcSEcCtD
Epirubicin—Hypersensitivity—Furosemide—coronary artery disease	3.5e-05	0.000132	CcSEcCtD
Epirubicin—Somnolence—Ramipril—coronary artery disease	3.5e-05	0.000132	CcSEcCtD
Epirubicin—Thrombocytopenia—Lisinopril—coronary artery disease	3.49e-05	0.000131	CcSEcCtD
Epirubicin—Dizziness—Trandolapril—coronary artery disease	3.49e-05	0.000131	CcSEcCtD
Epirubicin—Tachycardia—Lisinopril—coronary artery disease	3.48e-05	0.000131	CcSEcCtD
Epirubicin—Insomnia—Timolol—coronary artery disease	3.48e-05	0.000131	CcSEcCtD
Epirubicin—Rash—Niacin—coronary artery disease	3.48e-05	0.000131	CcSEcCtD
Epirubicin—Dermatitis—Niacin—coronary artery disease	3.47e-05	0.000131	CcSEcCtD
Epirubicin—Dizziness—Enalapril—coronary artery disease	3.47e-05	0.000131	CcSEcCtD
Epirubicin—Skin disorder—Lisinopril—coronary artery disease	3.47e-05	0.00013	CcSEcCtD
Epirubicin—Dyspepsia—Ramipril—coronary artery disease	3.46e-05	0.00013	CcSEcCtD
Epirubicin—Pruritus—Perindopril—coronary artery disease	3.46e-05	0.00013	CcSEcCtD
Epirubicin—Headache—Niacin—coronary artery disease	3.46e-05	0.00013	CcSEcCtD
Epirubicin—Paraesthesia—Timolol—coronary artery disease	3.45e-05	0.00013	CcSEcCtD
Epirubicin—Vomiting—Pravastatin—coronary artery disease	3.45e-05	0.00013	CcSEcCtD
Epirubicin—Hyperhidrosis—Lisinopril—coronary artery disease	3.45e-05	0.00013	CcSEcCtD
Epirubicin—Diarrhoea—Captopril—coronary artery disease	3.45e-05	0.00013	CcSEcCtD
Epirubicin—Dyspnoea—Timolol—coronary artery disease	3.43e-05	0.000129	CcSEcCtD
Epirubicin—Dizziness—Telmisartan—coronary artery disease	3.43e-05	0.000129	CcSEcCtD
Epirubicin—Rash—Pravastatin—coronary artery disease	3.42e-05	0.000129	CcSEcCtD
Epirubicin—Dermatitis—Pravastatin—coronary artery disease	3.42e-05	0.000129	CcSEcCtD
Epirubicin—Decreased appetite—Ramipril—coronary artery disease	3.42e-05	0.000129	CcSEcCtD
Epirubicin—Somnolence—Timolol—coronary artery disease	3.42e-05	0.000129	CcSEcCtD
Epirubicin—Asthenia—Furosemide—coronary artery disease	3.41e-05	0.000128	CcSEcCtD
Epirubicin—Headache—Pravastatin—coronary artery disease	3.4e-05	0.000128	CcSEcCtD
Epirubicin—Anorexia—Lisinopril—coronary artery disease	3.4e-05	0.000128	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Ramipril—coronary artery disease	3.4e-05	0.000128	CcSEcCtD
Epirubicin—Fatigue—Ramipril—coronary artery disease	3.39e-05	0.000128	CcSEcCtD
Epirubicin—Dyspepsia—Timolol—coronary artery disease	3.39e-05	0.000127	CcSEcCtD
Epirubicin—Hypersensitivity—Losartan—coronary artery disease	3.38e-05	0.000127	CcSEcCtD
Epirubicin—Nausea—Valsartan—coronary artery disease	3.37e-05	0.000127	CcSEcCtD
Epirubicin—Pruritus—Furosemide—coronary artery disease	3.36e-05	0.000127	CcSEcCtD
Epirubicin—Constipation—Ramipril—coronary artery disease	3.36e-05	0.000127	CcSEcCtD
Epirubicin—Nausea—Olmesartan—coronary artery disease	3.35e-05	0.000126	CcSEcCtD
Epirubicin—Vomiting—Trandolapril—coronary artery disease	3.35e-05	0.000126	CcSEcCtD
Epirubicin—Diarrhoea—Perindopril—coronary artery disease	3.35e-05	0.000126	CcSEcCtD
Epirubicin—Decreased appetite—Timolol—coronary artery disease	3.34e-05	0.000126	CcSEcCtD
Epirubicin—Vomiting—Enalapril—coronary artery disease	3.34e-05	0.000126	CcSEcCtD
Epirubicin—Hypotension—Lisinopril—coronary artery disease	3.33e-05	0.000125	CcSEcCtD
Epirubicin—Dizziness—Captopril—coronary artery disease	3.33e-05	0.000125	CcSEcCtD
Epirubicin—Rash—Trandolapril—coronary artery disease	3.33e-05	0.000125	CcSEcCtD
Epirubicin—Dermatitis—Trandolapril—coronary artery disease	3.32e-05	0.000125	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Timolol—coronary artery disease	3.32e-05	0.000125	CcSEcCtD
Epirubicin—Fatigue—Timolol—coronary artery disease	3.32e-05	0.000125	CcSEcCtD
Epirubicin—Rash—Enalapril—coronary artery disease	3.31e-05	0.000125	CcSEcCtD
Epirubicin—Dermatitis—Enalapril—coronary artery disease	3.31e-05	0.000124	CcSEcCtD
Epirubicin—Headache—Trandolapril—coronary artery disease	3.3e-05	0.000124	CcSEcCtD
Epirubicin—Vomiting—Telmisartan—coronary artery disease	3.29e-05	0.000124	CcSEcCtD
Epirubicin—Asthenia—Losartan—coronary artery disease	3.29e-05	0.000124	CcSEcCtD
Epirubicin—Headache—Enalapril—coronary artery disease	3.29e-05	0.000124	CcSEcCtD
Epirubicin—Pain—Timolol—coronary artery disease	3.29e-05	0.000124	CcSEcCtD
Epirubicin—Nausea—Niacin—coronary artery disease	3.28e-05	0.000123	CcSEcCtD
Epirubicin—Rash—Telmisartan—coronary artery disease	3.27e-05	0.000123	CcSEcCtD
Epirubicin—Dermatitis—Telmisartan—coronary artery disease	3.26e-05	0.000123	CcSEcCtD
Epirubicin—Diarrhoea—Furosemide—coronary artery disease	3.25e-05	0.000122	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Lisinopril—coronary artery disease	3.25e-05	0.000122	CcSEcCtD
Epirubicin—Pruritus—Losartan—coronary artery disease	3.25e-05	0.000122	CcSEcCtD
Epirubicin—Headache—Telmisartan—coronary artery disease	3.25e-05	0.000122	CcSEcCtD
Epirubicin—Feeling abnormal—Ramipril—coronary artery disease	3.24e-05	0.000122	CcSEcCtD
Epirubicin—Dizziness—Perindopril—coronary artery disease	3.23e-05	0.000122	CcSEcCtD
Epirubicin—Insomnia—Lisinopril—coronary artery disease	3.23e-05	0.000121	CcSEcCtD
Epirubicin—Nausea—Pravastatin—coronary artery disease	3.23e-05	0.000121	CcSEcCtD
Epirubicin—Gastrointestinal pain—Ramipril—coronary artery disease	3.22e-05	0.000121	CcSEcCtD
Epirubicin—Paraesthesia—Lisinopril—coronary artery disease	3.2e-05	0.00012	CcSEcCtD
Epirubicin—Vomiting—Captopril—coronary artery disease	3.2e-05	0.00012	CcSEcCtD
Epirubicin—Dyspnoea—Lisinopril—coronary artery disease	3.18e-05	0.00012	CcSEcCtD
Epirubicin—Rash—Captopril—coronary artery disease	3.18e-05	0.000119	CcSEcCtD
Epirubicin—Dermatitis—Captopril—coronary artery disease	3.17e-05	0.000119	CcSEcCtD
Epirubicin—Somnolence—Lisinopril—coronary artery disease	3.17e-05	0.000119	CcSEcCtD
Epirubicin—Feeling abnormal—Timolol—coronary artery disease	3.17e-05	0.000119	CcSEcCtD
Epirubicin—Headache—Captopril—coronary artery disease	3.16e-05	0.000119	CcSEcCtD
Epirubicin—Gastrointestinal pain—Timolol—coronary artery disease	3.15e-05	0.000118	CcSEcCtD
Epirubicin—Dizziness—Furosemide—coronary artery disease	3.14e-05	0.000118	CcSEcCtD
Epirubicin—Dyspepsia—Lisinopril—coronary artery disease	3.14e-05	0.000118	CcSEcCtD
Epirubicin—Diarrhoea—Losartan—coronary artery disease	3.14e-05	0.000118	CcSEcCtD
Epirubicin—Nausea—Trandolapril—coronary artery disease	3.13e-05	0.000118	CcSEcCtD
Epirubicin—Urticaria—Ramipril—coronary artery disease	3.13e-05	0.000118	CcSEcCtD
Epirubicin—Nausea—Enalapril—coronary artery disease	3.12e-05	0.000117	CcSEcCtD
Epirubicin—Vomiting—Perindopril—coronary artery disease	3.11e-05	0.000117	CcSEcCtD
Epirubicin—Abdominal pain—Ramipril—coronary artery disease	3.11e-05	0.000117	CcSEcCtD
Epirubicin—Body temperature increased—Ramipril—coronary artery disease	3.11e-05	0.000117	CcSEcCtD
Epirubicin—Decreased appetite—Lisinopril—coronary artery disease	3.1e-05	0.000117	CcSEcCtD
Epirubicin—Rash—Perindopril—coronary artery disease	3.08e-05	0.000116	CcSEcCtD
Epirubicin—Dermatitis—Perindopril—coronary artery disease	3.08e-05	0.000116	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Lisinopril—coronary artery disease	3.08e-05	0.000116	CcSEcCtD
Epirubicin—Nausea—Telmisartan—coronary artery disease	3.08e-05	0.000116	CcSEcCtD
Epirubicin—Fatigue—Lisinopril—coronary artery disease	3.08e-05	0.000116	CcSEcCtD
Epirubicin—Headache—Perindopril—coronary artery disease	3.06e-05	0.000115	CcSEcCtD
Epirubicin—Urticaria—Timolol—coronary artery disease	3.06e-05	0.000115	CcSEcCtD
Epirubicin—Constipation—Lisinopril—coronary artery disease	3.05e-05	0.000115	CcSEcCtD
Epirubicin—Pain—Lisinopril—coronary artery disease	3.05e-05	0.000115	CcSEcCtD
Epirubicin—Abdominal pain—Timolol—coronary artery disease	3.04e-05	0.000114	CcSEcCtD
Epirubicin—Body temperature increased—Timolol—coronary artery disease	3.04e-05	0.000114	CcSEcCtD
Epirubicin—Dizziness—Losartan—coronary artery disease	3.03e-05	0.000114	CcSEcCtD
Epirubicin—Vomiting—Furosemide—coronary artery disease	3.02e-05	0.000114	CcSEcCtD
Epirubicin—Rash—Furosemide—coronary artery disease	3e-05	0.000113	CcSEcCtD
Epirubicin—Dermatitis—Furosemide—coronary artery disease	3e-05	0.000113	CcSEcCtD
Epirubicin—Nausea—Captopril—coronary artery disease	2.99e-05	0.000113	CcSEcCtD
Epirubicin—Headache—Furosemide—coronary artery disease	2.98e-05	0.000112	CcSEcCtD
Epirubicin—Feeling abnormal—Lisinopril—coronary artery disease	2.94e-05	0.000111	CcSEcCtD
Epirubicin—Gastrointestinal pain—Lisinopril—coronary artery disease	2.92e-05	0.00011	CcSEcCtD
Epirubicin—Vomiting—Losartan—coronary artery disease	2.92e-05	0.00011	CcSEcCtD
Epirubicin—Nausea—Perindopril—coronary artery disease	2.91e-05	0.000109	CcSEcCtD
Epirubicin—Hypersensitivity—Ramipril—coronary artery disease	2.9e-05	0.000109	CcSEcCtD
Epirubicin—Rash—Losartan—coronary artery disease	2.89e-05	0.000109	CcSEcCtD
Epirubicin—Dermatitis—Losartan—coronary artery disease	2.89e-05	0.000109	CcSEcCtD
Epirubicin—Headache—Losartan—coronary artery disease	2.87e-05	0.000108	CcSEcCtD
Epirubicin—Urticaria—Lisinopril—coronary artery disease	2.83e-05	0.000107	CcSEcCtD
Epirubicin—Hypersensitivity—Timolol—coronary artery disease	2.83e-05	0.000107	CcSEcCtD
Epirubicin—Nausea—Furosemide—coronary artery disease	2.82e-05	0.000106	CcSEcCtD
Epirubicin—Asthenia—Ramipril—coronary artery disease	2.82e-05	0.000106	CcSEcCtD
Epirubicin—Body temperature increased—Lisinopril—coronary artery disease	2.82e-05	0.000106	CcSEcCtD
Epirubicin—Abdominal pain—Lisinopril—coronary artery disease	2.82e-05	0.000106	CcSEcCtD
Epirubicin—Pruritus—Ramipril—coronary artery disease	2.78e-05	0.000105	CcSEcCtD
Epirubicin—Asthenia—Timolol—coronary artery disease	2.76e-05	0.000104	CcSEcCtD
Epirubicin—Nausea—Losartan—coronary artery disease	2.73e-05	0.000102	CcSEcCtD
Epirubicin—Pruritus—Timolol—coronary artery disease	2.72e-05	0.000102	CcSEcCtD
Epirubicin—Diarrhoea—Ramipril—coronary artery disease	2.69e-05	0.000101	CcSEcCtD
Epirubicin—Diarrhoea—Timolol—coronary artery disease	2.63e-05	9.9e-05	CcSEcCtD
Epirubicin—Hypersensitivity—Lisinopril—coronary artery disease	2.63e-05	9.89e-05	CcSEcCtD
Epirubicin—Dizziness—Ramipril—coronary artery disease	2.6e-05	9.78e-05	CcSEcCtD
Epirubicin—Asthenia—Lisinopril—coronary artery disease	2.56e-05	9.63e-05	CcSEcCtD
Epirubicin—Dizziness—Timolol—coronary artery disease	2.54e-05	9.57e-05	CcSEcCtD
Epirubicin—Pruritus—Lisinopril—coronary artery disease	2.52e-05	9.49e-05	CcSEcCtD
Epirubicin—Vomiting—Ramipril—coronary artery disease	2.5e-05	9.41e-05	CcSEcCtD
Epirubicin—Rash—Ramipril—coronary artery disease	2.48e-05	9.33e-05	CcSEcCtD
Epirubicin—Dermatitis—Ramipril—coronary artery disease	2.48e-05	9.32e-05	CcSEcCtD
Epirubicin—Headache—Ramipril—coronary artery disease	2.46e-05	9.27e-05	CcSEcCtD
Epirubicin—Vomiting—Timolol—coronary artery disease	2.45e-05	9.2e-05	CcSEcCtD
Epirubicin—Diarrhoea—Lisinopril—coronary artery disease	2.44e-05	9.18e-05	CcSEcCtD
Epirubicin—Rash—Timolol—coronary artery disease	2.43e-05	9.12e-05	CcSEcCtD
Epirubicin—Dermatitis—Timolol—coronary artery disease	2.42e-05	9.11e-05	CcSEcCtD
Epirubicin—Headache—Timolol—coronary artery disease	2.41e-05	9.06e-05	CcSEcCtD
Epirubicin—Dizziness—Lisinopril—coronary artery disease	2.36e-05	8.87e-05	CcSEcCtD
Epirubicin—Nausea—Ramipril—coronary artery disease	2.34e-05	8.79e-05	CcSEcCtD
Epirubicin—Nausea—Timolol—coronary artery disease	2.28e-05	8.59e-05	CcSEcCtD
Epirubicin—Vomiting—Lisinopril—coronary artery disease	2.27e-05	8.53e-05	CcSEcCtD
Epirubicin—Rash—Lisinopril—coronary artery disease	2.25e-05	8.46e-05	CcSEcCtD
Epirubicin—Dermatitis—Lisinopril—coronary artery disease	2.25e-05	8.45e-05	CcSEcCtD
Epirubicin—Headache—Lisinopril—coronary artery disease	2.24e-05	8.41e-05	CcSEcCtD
Epirubicin—Nausea—Lisinopril—coronary artery disease	2.12e-05	7.97e-05	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—CCR3—coronary artery disease	1.17e-05	7.97e-05	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—CCND1—coronary artery disease	1.16e-05	7.91e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CRK—coronary artery disease	1.16e-05	7.87e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—coronary artery disease	1.15e-05	7.83e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—DCN—coronary artery disease	1.15e-05	7.83e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SH2B3—coronary artery disease	1.14e-05	7.77e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—VWF—coronary artery disease	1.14e-05	7.77e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ATP2A2—coronary artery disease	1.14e-05	7.77e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—GOT2—coronary artery disease	1.14e-05	7.74e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—APOC3—coronary artery disease	1.14e-05	7.72e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CYBA—coronary artery disease	1.13e-05	7.7e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—LDLR—coronary artery disease	1.13e-05	7.68e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CALR—coronary artery disease	1.13e-05	7.67e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALDH2—coronary artery disease	1.12e-05	7.62e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PLCB1—coronary artery disease	1.12e-05	7.6e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PPP2CA—coronary artery disease	1.11e-05	7.53e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCL2—coronary artery disease	1.1e-05	7.5e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCL3—coronary artery disease	1.1e-05	7.5e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PLCB1—coronary artery disease	1.1e-05	7.46e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	1.09e-05	7.43e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—LIPC—coronary artery disease	1.09e-05	7.43e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP2C19—coronary artery disease	1.09e-05	7.43e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PIK3C2A—coronary artery disease	1.09e-05	7.43e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—HBA1—coronary artery disease	1.09e-05	7.43e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SDC1—coronary artery disease	1.09e-05	7.41e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—F2R—coronary artery disease	1.09e-05	7.41e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PRKCD—coronary artery disease	1.09e-05	7.4e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—APOC3—coronary artery disease	1.09e-05	7.38e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ABCA1—coronary artery disease	1.08e-05	7.37e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—LDLR—coronary artery disease	1.08e-05	7.34e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.08e-05	7.33e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.08e-05	7.31e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FGB—coronary artery disease	1.07e-05	7.26e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SLC9A1—coronary artery disease	1.07e-05	7.25e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTT1—coronary artery disease	1.07e-05	7.25e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—HTR2A—coronary artery disease	1.06e-05	7.24e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—C3—coronary artery disease	1.06e-05	7.23e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ABCA1—coronary artery disease	1.06e-05	7.23e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EDNRB—coronary artery disease	1.06e-05	7.18e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CETP—coronary artery disease	1.05e-05	7.16e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GCLC—coronary artery disease	1.05e-05	7.16e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—JUNB—coronary artery disease	1.05e-05	7.14e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HSPA1A—coronary artery disease	1.05e-05	7.14e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GGT1—coronary artery disease	1.05e-05	7.14e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GOT1—coronary artery disease	1.05e-05	7.14e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SDC1—coronary artery disease	1.04e-05	7.08e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—THBS1—coronary artery disease	1.04e-05	7.07e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PSMA6—coronary artery disease	1.03e-05	7e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PSMB5—coronary artery disease	1.03e-05	7e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GOT1—coronary artery disease	1.03e-05	7e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GGT1—coronary artery disease	1.03e-05	7e-05	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—MAPK1—coronary artery disease	1.02e-05	6.94e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AGT—coronary artery disease	1.01e-05	6.87e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EDNRA—coronary artery disease	9.98e-06	6.78e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CYBA—coronary artery disease	9.93e-06	6.75e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ADRB1—coronary artery disease	9.93e-06	6.75e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—DUSP6—coronary artery disease	9.89e-06	6.72e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PSMB5—coronary artery disease	9.85e-06	6.69e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PSMA6—coronary artery disease	9.85e-06	6.69e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	9.83e-06	6.68e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—GOT1—coronary artery disease	9.82e-06	6.68e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PLAT—coronary artery disease	9.72e-06	6.61e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CTGF—coronary artery disease	9.62e-06	6.54e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—HMGCR—coronary artery disease	9.53e-06	6.48e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GOT2—coronary artery disease	9.53e-06	6.48e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GSTP1—coronary artery disease	9.43e-06	6.41e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCL12—coronary artery disease	9.38e-06	6.38e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—BDKRB2—coronary artery disease	9.38e-06	6.38e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PPARGC1A—coronary artery disease	9.34e-06	6.35e-05	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ALB—coronary artery disease	9.34e-06	6.35e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—F2—coronary artery disease	9.34e-06	6.35e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—VEGFA—coronary artery disease	9.31e-06	6.33e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—HMOX1—coronary artery disease	9.3e-06	6.32e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL6ST—coronary artery disease	9.3e-06	6.32e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GSTP1—coronary artery disease	9.25e-06	6.29e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—JUNB—coronary artery disease	9.21e-06	6.26e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CAT—coronary artery disease	9.18e-06	6.24e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PLCB1—coronary artery disease	9.17e-06	6.24e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PPARGC1A—coronary artery disease	9.16e-06	6.23e-05	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—MAPK1—coronary artery disease	9.13e-06	6.21e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—HMOX1—coronary artery disease	9.12e-06	6.2e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PRKCE—coronary artery disease	9.06e-06	6.16e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CAT—coronary artery disease	9e-06	6.12e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HTR7—coronary artery disease	8.98e-06	6.11e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—APOB—coronary artery disease	8.91e-06	6.06e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TGFBR2—coronary artery disease	8.83e-06	6e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—KITLG—coronary artery disease	8.83e-06	6e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PLCB1—coronary artery disease	8.76e-06	5.96e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—APOB—coronary artery disease	8.74e-06	5.94e-05	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PIK3CA—coronary artery disease	8.71e-06	5.92e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GSTM1—coronary artery disease	8.67e-06	5.89e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—STAT5A—coronary artery disease	8.63e-06	5.86e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	8.6e-06	5.84e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ITGAV—coronary artery disease	8.56e-06	5.82e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TGFB1—coronary artery disease	8.55e-06	5.81e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KNG1—coronary artery disease	8.53e-06	5.8e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—LPL—coronary artery disease	8.51e-06	5.78e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—POMC—coronary artery disease	8.5e-06	5.78e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CREB1—coronary artery disease	8.5e-06	5.78e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GSTM1—coronary artery disease	8.5e-06	5.78e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ABCA1—coronary artery disease	8.5e-06	5.78e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AGTR1—coronary artery disease	8.48e-06	5.77e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—MAPK1—coronary artery disease	8.38e-06	5.7e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—LPL—coronary artery disease	8.34e-06	5.67e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—APOB—coronary artery disease	8.34e-06	5.67e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CCL2—coronary artery disease	8.32e-06	5.66e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GPX1—coronary artery disease	8.3e-06	5.64e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL6R—coronary artery disease	8.3e-06	5.64e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCL10—coronary artery disease	8.29e-06	5.63e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PLG—coronary artery disease	8.27e-06	5.62e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GOT1—coronary artery disease	8.23e-06	5.59e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GGT1—coronary artery disease	8.23e-06	5.59e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GPX1—coronary artery disease	8.14e-06	5.53e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CD36—coronary artery disease	8.08e-06	5.5e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ADRB2—coronary artery disease	8.05e-06	5.47e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—FGF1—coronary artery disease	8.02e-06	5.45e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PPP2CA—coronary artery disease	7.98e-06	5.43e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—LPL—coronary artery disease	7.96e-06	5.41e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PRKCE—coronary artery disease	7.94e-06	5.4e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CD36—coronary artery disease	7.93e-06	5.39e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SOCS1—coronary artery disease	7.92e-06	5.39e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—S100B—coronary artery disease	7.9e-06	5.37e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PPP2CA—coronary artery disease	7.83e-06	5.32e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SOCS3—coronary artery disease	7.83e-06	5.32e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KITLG—coronary artery disease	7.73e-06	5.26e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TGFBR2—coronary artery disease	7.73e-06	5.26e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—MTHFR—coronary artery disease	7.66e-06	5.21e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—STAT5A—coronary artery disease	7.56e-06	5.14e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MMP3—coronary artery disease	7.56e-06	5.14e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—MTHFR—coronary artery disease	7.51e-06	5.11e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PPP2CA—coronary artery disease	7.47e-06	5.08e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTP1—coronary artery disease	7.39e-06	5.02e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PRKCD—coronary artery disease	7.33e-06	4.99e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PPARGC1A—coronary artery disease	7.32e-06	4.98e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—APOB—coronary artery disease	7.31e-06	4.97e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—HMOX1—coronary artery disease	7.29e-06	4.95e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—AGT—coronary artery disease	7.28e-06	4.95e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PIK3CA—coronary artery disease	7.27e-06	4.94e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—JAK2—coronary artery disease	7.21e-06	4.9e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CAT—coronary artery disease	7.19e-06	4.89e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EDN1—coronary artery disease	7.19e-06	4.89e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MTHFR—coronary artery disease	7.17e-06	4.87e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—AGT—coronary artery disease	7.14e-06	4.85e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCL5—coronary artery disease	7.13e-06	4.85e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—APOE—coronary artery disease	7.13e-06	4.85e-05	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—AKT1—coronary artery disease	7.12e-06	4.84e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—APOA1—coronary artery disease	7.05e-06	4.79e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FGF1—coronary artery disease	7.03e-06	4.78e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CSF2—coronary artery disease	7.03e-06	4.78e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—APOE—coronary artery disease	6.99e-06	4.75e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—APOB—coronary artery disease	6.98e-06	4.75e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—LPL—coronary artery disease	6.98e-06	4.74e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RPS6KB1—coronary artery disease	6.91e-06	4.7e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MEF2C—coronary artery disease	6.91e-06	4.7e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—APOA1—coronary artery disease	6.91e-06	4.7e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HIF1A—coronary artery disease	6.84e-06	4.65e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTM1—coronary artery disease	6.79e-06	4.62e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ITGB3—coronary artery disease	6.74e-06	4.58e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—APOE—coronary artery disease	6.67e-06	4.54e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—LPL—coronary artery disease	6.67e-06	4.53e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	6.62e-06	4.5e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—APOA1—coronary artery disease	6.6e-06	4.48e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCL8—coronary artery disease	6.58e-06	4.47e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PPP2CA—coronary artery disease	6.55e-06	4.45e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GPX1—coronary artery disease	6.5e-06	4.42e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PRKCD—coronary artery disease	6.43e-06	4.37e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CD36—coronary artery disease	6.33e-06	4.31e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HTR2A—coronary artery disease	6.29e-06	4.28e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—C3—coronary artery disease	6.28e-06	4.27e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IL6ST—coronary artery disease	6.27e-06	4.26e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PPP2CA—coronary artery disease	6.25e-06	4.25e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS2—coronary artery disease	6.22e-06	4.23e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PPARG—coronary artery disease	6.21e-06	4.22e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—POMC—coronary artery disease	6.13e-06	4.16e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PPARG—coronary artery disease	6.09e-06	4.14e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—KIT—coronary artery disease	6.02e-06	4.09e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—POMC—coronary artery disease	6.01e-06	4.08e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—MTHFR—coronary artery disease	6e-06	4.08e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HIF1A—coronary artery disease	5.99e-06	4.07e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AGT—coronary artery disease	5.97e-06	4.06e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—AKT1—coronary artery disease	5.94e-06	4.04e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—LEP—coronary artery disease	5.85e-06	3.98e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—APOE—coronary artery disease	5.85e-06	3.98e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—APOA1—coronary artery disease	5.78e-06	3.93e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—GSK3B—coronary artery disease	5.78e-06	3.93e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CREB1—coronary artery disease	5.73e-06	3.9e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KDR—coronary artery disease	5.73e-06	3.89e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—AGT—coronary artery disease	5.7e-06	3.88e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MAPK14—coronary artery disease	5.69e-06	3.87e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IL6R—coronary artery disease	5.59e-06	3.8e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—APOE—coronary artery disease	5.59e-06	3.8e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ALB—coronary artery disease	5.59e-06	3.8e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ESR1—coronary artery disease	5.58e-06	3.8e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—APOA1—coronary artery disease	5.52e-06	3.76e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FN1—coronary artery disease	5.51e-06	3.75e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—F2—coronary artery disease	5.51e-06	3.75e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL6ST—coronary artery disease	5.49e-06	3.73e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALB—coronary artery disease	5.48e-06	3.72e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NFKBIA—coronary artery disease	5.45e-06	3.7e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—NOS3—coronary artery disease	5.34e-06	3.63e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	5.29e-06	3.6e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KIT—coronary artery disease	5.28e-06	3.59e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—NOS3—coronary artery disease	5.24e-06	3.56e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SERPINE1—coronary artery disease	5.24e-06	3.56e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—FGF2—coronary artery disease	5.07e-06	3.45e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—GSK3B—coronary artery disease	5.06e-06	3.44e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—POMC—coronary artery disease	5.02e-06	3.41e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CREB1—coronary artery disease	5.02e-06	3.41e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS3—coronary artery disease	5e-06	3.4e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCL2—coronary artery disease	4.92e-06	3.34e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL6R—coronary artery disease	4.9e-06	3.33e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PTGS2—coronary artery disease	4.89e-06	3.32e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PPARG—coronary artery disease	4.87e-06	3.31e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—JAK2—coronary artery disease	4.86e-06	3.3e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IGF1—coronary artery disease	4.83e-06	3.28e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—MAPK1—coronary artery disease	4.81e-06	3.27e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—POMC—coronary artery disease	4.8e-06	3.26e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PTGS2—coronary artery disease	4.79e-06	3.26e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SERPINE1—coronary artery disease	4.59e-06	3.12e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PTGS2—coronary artery disease	4.57e-06	3.11e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FGF2—coronary artery disease	4.44e-06	3.02e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NOS3—coronary artery disease	4.38e-06	2.98e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALB—coronary artery disease	4.38e-06	2.98e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—JAK2—coronary artery disease	4.26e-06	2.89e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—NOS3—coronary artery disease	4.19e-06	2.85e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PIK3CA—coronary artery disease	4.17e-06	2.84e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCL8—coronary artery disease	3.89e-06	2.64e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PTGS2—coronary artery disease	3.83e-06	2.6e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CASP3—coronary artery disease	3.72e-06	2.53e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL6—coronary artery disease	3.7e-06	2.51e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CCND1—coronary artery disease	3.62e-06	2.46e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MMP9—coronary artery disease	3.52e-06	2.39e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—AKT1—coronary artery disease	3.41e-06	2.32e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TGFB1—coronary artery disease	3.31e-06	2.25e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MAPK1—coronary artery disease	3.24e-06	2.2e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—VEGFA—coronary artery disease	3.16e-06	2.15e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PIK3CA—coronary artery disease	3.01e-06	2.04e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PIK3CA—coronary artery disease	2.95e-06	2e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TGFB1—coronary artery disease	2.9e-06	1.97e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MAPK1—coronary artery disease	2.84e-06	1.93e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PIK3CA—coronary artery disease	2.81e-06	1.91e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IL6—coronary artery disease	2.49e-06	1.69e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PIK3CA—coronary artery disease	2.47e-06	1.68e-05	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—AKT1—coronary artery disease	2.46e-06	1.67e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—AKT1—coronary artery disease	2.41e-06	1.64e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PIK3CA—coronary artery disease	2.36e-06	1.6e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—AKT1—coronary artery disease	2.3e-06	1.56e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL6—coronary artery disease	2.18e-06	1.48e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—AKT1—coronary artery disease	2.01e-06	1.37e-05	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—AKT1—coronary artery disease	1.92e-06	1.31e-05	CbGpPWpGaD
